Bright Minds Biosciences Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Bright Minds Biosciences Inc had 225.33M in cash and cash equivalents.

Bright Minds Biosciences Inc reported 1.74M in total liabilities as of the latest reported quarter, including 1.71M in current liabilities and 30.14K in non-current liabilities.

As of the latest reported quarter, Bright Minds Biosciences Inc's total assets were 61.68M, consisting of 61.60M in current assets and 81.81K in non-current assets.

Bright Minds Biosciences Inc reported 59.95M in total shareholders' equity as of the latest reported quarter.